BCL2L1 and neoplasm: Significant tumor regression arising from synergistic inhibition of BCL‐XL and MCL1 has not yet been reported for HGSOC, but is known to induce solid tumor regression in other cancers.11, 12, 13, 14, 15, 16, 17, 18, 19, 20